Antitumor agents 295. E-ring hydroxylated antofine and cryptopleurine analogues as antiproliferative agents: Design, synthesis, and mechanistic studies

Xiaoming Yang, Qian Shi, Chin Yu Lai, Chi Yuan Chen, Emika Ohkoshi, Shuenn Chen Yang, Chih Ya Wang, Kenneth F. Bastow, Tian Shung Wu, Shiow Lin Pan, Che Ming Teng, Pan Chyr Yang, Kuo Hsiung Lee

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Various E-ring hydroxylated antofine and cryptopleurine analogues were designed, synthesized, and tested against five human cancer cell lines. Interesting structure-activity relationship (SAR) correlations were found among these new compounds. The most potent compound 13b was further tested against a series of nonsmall cell lung cancer (NSCLC) cell lines in which it showed impressive antiproliferative activity. Mechanistic studies revealed that 13b is able to down-regulate HSP90 and β-catenin in A549 lung adenocarcinoma cells in a dose-dependent manner, suggesting a potential use for treating hedgehog pathway-driven tumorigenesis.

Original languageEnglish
Pages (from-to)6751-6761
Number of pages11
JournalJournal of Medicinal Chemistry
Volume55
Issue number15
DOIs
Publication statusPublished - Aug 9 2012
Externally publishedYes

Fingerprint

Antineoplastic Agents
Cell Line
Catenins
Structure-Activity Relationship
Non-Small Cell Lung Carcinoma
Carcinogenesis
Down-Regulation
Neoplasms
cryptopleurine
antofine
Adenocarcinoma of lung

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Antitumor agents 295. E-ring hydroxylated antofine and cryptopleurine analogues as antiproliferative agents : Design, synthesis, and mechanistic studies. / Yang, Xiaoming; Shi, Qian; Lai, Chin Yu; Chen, Chi Yuan; Ohkoshi, Emika; Yang, Shuenn Chen; Wang, Chih Ya; Bastow, Kenneth F.; Wu, Tian Shung; Pan, Shiow Lin; Teng, Che Ming; Yang, Pan Chyr; Lee, Kuo Hsiung.

In: Journal of Medicinal Chemistry, Vol. 55, No. 15, 09.08.2012, p. 6751-6761.

Research output: Contribution to journalArticle

Yang, X, Shi, Q, Lai, CY, Chen, CY, Ohkoshi, E, Yang, SC, Wang, CY, Bastow, KF, Wu, TS, Pan, SL, Teng, CM, Yang, PC & Lee, KH 2012, 'Antitumor agents 295. E-ring hydroxylated antofine and cryptopleurine analogues as antiproliferative agents: Design, synthesis, and mechanistic studies', Journal of Medicinal Chemistry, vol. 55, no. 15, pp. 6751-6761. https://doi.org/10.1021/jm3001218
Yang, Xiaoming ; Shi, Qian ; Lai, Chin Yu ; Chen, Chi Yuan ; Ohkoshi, Emika ; Yang, Shuenn Chen ; Wang, Chih Ya ; Bastow, Kenneth F. ; Wu, Tian Shung ; Pan, Shiow Lin ; Teng, Che Ming ; Yang, Pan Chyr ; Lee, Kuo Hsiung. / Antitumor agents 295. E-ring hydroxylated antofine and cryptopleurine analogues as antiproliferative agents : Design, synthesis, and mechanistic studies. In: Journal of Medicinal Chemistry. 2012 ; Vol. 55, No. 15. pp. 6751-6761.
@article{e400d5761d474df4ba2d161b17474cc0,
title = "Antitumor agents 295. E-ring hydroxylated antofine and cryptopleurine analogues as antiproliferative agents: Design, synthesis, and mechanistic studies",
abstract = "Various E-ring hydroxylated antofine and cryptopleurine analogues were designed, synthesized, and tested against five human cancer cell lines. Interesting structure-activity relationship (SAR) correlations were found among these new compounds. The most potent compound 13b was further tested against a series of nonsmall cell lung cancer (NSCLC) cell lines in which it showed impressive antiproliferative activity. Mechanistic studies revealed that 13b is able to down-regulate HSP90 and β-catenin in A549 lung adenocarcinoma cells in a dose-dependent manner, suggesting a potential use for treating hedgehog pathway-driven tumorigenesis.",
author = "Xiaoming Yang and Qian Shi and Lai, {Chin Yu} and Chen, {Chi Yuan} and Emika Ohkoshi and Yang, {Shuenn Chen} and Wang, {Chih Ya} and Bastow, {Kenneth F.} and Wu, {Tian Shung} and Pan, {Shiow Lin} and Teng, {Che Ming} and Yang, {Pan Chyr} and Lee, {Kuo Hsiung}",
year = "2012",
month = "8",
day = "9",
doi = "10.1021/jm3001218",
language = "English",
volume = "55",
pages = "6751--6761",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "15",

}

TY - JOUR

T1 - Antitumor agents 295. E-ring hydroxylated antofine and cryptopleurine analogues as antiproliferative agents

T2 - Design, synthesis, and mechanistic studies

AU - Yang, Xiaoming

AU - Shi, Qian

AU - Lai, Chin Yu

AU - Chen, Chi Yuan

AU - Ohkoshi, Emika

AU - Yang, Shuenn Chen

AU - Wang, Chih Ya

AU - Bastow, Kenneth F.

AU - Wu, Tian Shung

AU - Pan, Shiow Lin

AU - Teng, Che Ming

AU - Yang, Pan Chyr

AU - Lee, Kuo Hsiung

PY - 2012/8/9

Y1 - 2012/8/9

N2 - Various E-ring hydroxylated antofine and cryptopleurine analogues were designed, synthesized, and tested against five human cancer cell lines. Interesting structure-activity relationship (SAR) correlations were found among these new compounds. The most potent compound 13b was further tested against a series of nonsmall cell lung cancer (NSCLC) cell lines in which it showed impressive antiproliferative activity. Mechanistic studies revealed that 13b is able to down-regulate HSP90 and β-catenin in A549 lung adenocarcinoma cells in a dose-dependent manner, suggesting a potential use for treating hedgehog pathway-driven tumorigenesis.

AB - Various E-ring hydroxylated antofine and cryptopleurine analogues were designed, synthesized, and tested against five human cancer cell lines. Interesting structure-activity relationship (SAR) correlations were found among these new compounds. The most potent compound 13b was further tested against a series of nonsmall cell lung cancer (NSCLC) cell lines in which it showed impressive antiproliferative activity. Mechanistic studies revealed that 13b is able to down-regulate HSP90 and β-catenin in A549 lung adenocarcinoma cells in a dose-dependent manner, suggesting a potential use for treating hedgehog pathway-driven tumorigenesis.

UR - http://www.scopus.com/inward/record.url?scp=84864960006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864960006&partnerID=8YFLogxK

U2 - 10.1021/jm3001218

DO - 10.1021/jm3001218

M3 - Article

C2 - 22823514

AN - SCOPUS:84864960006

VL - 55

SP - 6751

EP - 6761

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 15

ER -